
Oxalimax 50mg Injection
Marketer
GLS Pharma Ltd.
Salt Composition
Oxaliplatin (50mg)
Overview Oxalimax 50mg Injection
Colontox 50mg Injection treats colorectal cancer by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can cause severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, fatigue, vomiting, and diarrhea. This medication can reduce blood cell counts (red and white), increasing infection risk. Severe allergic reactions, indicated by lip sores, mouth ulcers, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitor blood cell levels, alongside heart, liver, and uric acid levels. Inform your doctor of pre-existing heart, liver, or kidney conditions, and any concurrent medications, especially those for infections; many drug interactions are possible. Use is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm cryopreservation should be discussed with your doctor. Due to potential dizziness, driving is discouraged after administration.
Uses of Oxalimax 50mg Injection
Colorectal cancer
Major Benefits of Oxalimax 50mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Oxalimax 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxalimax 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Oxalimax 50mg Injection works:
Cellax 50mg injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the cancerous cells' genetic blueprint (DNA and RNA), thus inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oxalimax 50mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxalimax 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Oxalimax 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Oxalimax 50mg Injection can induce adverse reactions potentially impairing driving ability. Oxaliplatin therapy may elevate the likelihood of experiencing dizziness, nausea, vomiting, and other neurological manifestations impacting gait, thereby affecting driving aptitude.
KidneyCAUTION
For individuals with severely impaired kidney function, Oxalimax 50mg Injection requires careful administration and potential dosage modification. Consult a physician for guidance. Data on Oxalimax 50mg Injection use in such patients is limited. Dosage alteration isn't advised for those with mildly or moderately impaired kidney function.
LiverCAUTION
For individuals with hepatic impairment, administration of Oxalimax 50mg Injection requires careful consideration. Dosage modification of Oxalimax 50mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Oxalimax 50mg Injection :
Omit a dose of Oxalimax 50mg Injection? Seek your physician's advice.
Facts to Know About Oxalimax 50mg Injection
Label | Value |
---|---|
Chemical Type | Platinum Equivalents |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Actions | Platinum-based anticancer agents |